Cronos Group Inc. cash flow statement
In fiscal 2025, Cronos Group Inc.'s operations generated $25.9m of cash; it spent $25.7m on capital projects, leaving free cash flow of $149,000. It returned $9.7m through buybacks.
Cash flow statement
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −4 | −8 | −131 | −145 | −154 | −89 | −43 | 19 | 26 | 60 |
| Depreciation and amortisation | 1 | 2 | 4 | 7 | 15 | 13 | 8 | 9 | 14 | 8 |
| Stock-based pay | 2 | 8 | 12 | 15 | 10 | 15 | 9 | 9 | 7 | 6 |
| Capital spending | 33 | 88 | 39 | 31 | 11 | 3 | 3 | 12 | 26 | 10 |
| Free cash flow | −37 | −96 | −170 | −176 | −165 | −92 | −45 | 6 | 0 | 50 |
| Free cash flow after stock pay | −39 | −104 | −181 | −192 | −175 | −108 | −54 | −2 | −7 | 43 |
| Share buybacks | — | — | — | — | — | — | 0 | 0 | 10 | 39 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 12 | 8 | −2 | 3 | 13 | 12 | 11 | 24 |
| Depreciation and amortisation | 1 | 3 | 3 | 1 | 0 | 4 | 4 | 0 |
| Stock-based pay | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 2 |
| Capital spending | 6 | 4 | 15 | 4 | 4 | 2 | 2 | 2 |
| Free cash flow | 5 | 4 | −17 | −1 | 9 | 10 | 9 | 22 |
| Free cash flow after stock pay | 3 | 2 | −19 | −2 | 6 | 8 | 8 | 21 |
Compare with peers
- Kamada LTD cash flow
- Amarin Corp plc\uk cash flow
- Biote Corp. cash flow
- Organigram Global Inc. cash flow
- Heron Therapeutics, Inc. cash flow
Head to head: CRON vs KMDAAMRN vs CRONBTMD vs CRONCRON vs OGI
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies